| Product Code: ETC11635573 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
Latvia`s import of cholesterol lowering agents in 2024 was primarily sourced from neighboring Lithuania, along with key suppliers such as Netherlands, Switzerland, Poland, and Germany. The market exhibited low concentration with a stable Herfindahl-Hirschman Index (HHI). A notable compound annual growth rate (CAGR) of 8.6% from 2020 to 2024 highlights the increasing demand for these products. The growth momentum continued into 2024 with a solid growth rate of 7.03%, indicating a positive trajectory for the market in Latvia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Cholesterol Lowering Agents Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Cholesterol Lowering Agents Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Cholesterol Lowering Agents Market - Industry Life Cycle |
3.4 Latvia Cholesterol Lowering Agents Market - Porter's Five Forces |
3.5 Latvia Cholesterol Lowering Agents Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Latvia Cholesterol Lowering Agents Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 Latvia Cholesterol Lowering Agents Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Latvia Cholesterol Lowering Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Latvia |
4.2.2 Growing awareness about the importance of cholesterol management in maintaining heart health |
4.2.3 Rising adoption of unhealthy lifestyles leading to higher cholesterol levels |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for cholesterol lowering agents in Latvia |
4.3.2 Limited availability of advanced and innovative cholesterol lowering drugs in the market |
5 Latvia Cholesterol Lowering Agents Market Trends |
6 Latvia Cholesterol Lowering Agents Market, By Types |
6.1 Latvia Cholesterol Lowering Agents Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Latvia Cholesterol Lowering Agents Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 Latvia Cholesterol Lowering Agents Market Revenues & Volume, By Statins, 2021 - 2031F |
6.1.4 Latvia Cholesterol Lowering Agents Market Revenues & Volume, By Bile Acid Sequestrants, 2021 - 2031F |
6.1.5 Latvia Cholesterol Lowering Agents Market Revenues & Volume, By Nicotinic Acid, 2021 - 2031F |
6.1.6 Latvia Cholesterol Lowering Agents Market Revenues & Volume, By PCSK9 Inhibitors, 2021 - 2031F |
6.1.7 Latvia Cholesterol Lowering Agents Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Latvia Cholesterol Lowering Agents Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 Latvia Cholesterol Lowering Agents Market Revenues & Volume, By Hypercholesterolemia, 2021 - 2031F |
6.2.3 Latvia Cholesterol Lowering Agents Market Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031F |
6.2.4 Latvia Cholesterol Lowering Agents Market Revenues & Volume, By Hyperlipidemia, 2021 - 2031F |
6.3 Latvia Cholesterol Lowering Agents Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Latvia Cholesterol Lowering Agents Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.3.3 Latvia Cholesterol Lowering Agents Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.3.4 Latvia Cholesterol Lowering Agents Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 Latvia Cholesterol Lowering Agents Market Import-Export Trade Statistics |
7.1 Latvia Cholesterol Lowering Agents Market Export to Major Countries |
7.2 Latvia Cholesterol Lowering Agents Market Imports from Major Countries |
8 Latvia Cholesterol Lowering Agents Market Key Performance Indicators |
8.1 Patient adherence rates to prescribed cholesterol lowering medications |
8.2 Average time taken for new cholesterol lowering agents to gain regulatory approval in Latvia |
8.3 Number of educational campaigns and initiatives focused on cholesterol management in the country |
9 Latvia Cholesterol Lowering Agents Market - Opportunity Assessment |
9.1 Latvia Cholesterol Lowering Agents Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Latvia Cholesterol Lowering Agents Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 Latvia Cholesterol Lowering Agents Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Latvia Cholesterol Lowering Agents Market - Competitive Landscape |
10.1 Latvia Cholesterol Lowering Agents Market Revenue Share, By Companies, 2024 |
10.2 Latvia Cholesterol Lowering Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here